Table 2.
Time | Patent | Occluded | Not sure |
---|---|---|---|
Day21LV | 3 | 4 | 5 |
Day21C | 5 | 5 | 1 |
Day28LV | 3 | 4 | 5 |
Day28C | 2 | 6 | 3 |
Day42LV | 4 | 8 | 0 |
Day42C | 1 | 9 | 1 |
LV= LV-shRNA-Vegf-A treated vessels
C= control shRNA treated vessels
D21: day 21 after AVF placement
D28: day 28 after AVF placement
D42: day 42 after AVF placement